Jocelyn Nava
Overview
Explore the profile of Jocelyn Nava including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
2
Citations
18
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Corominas J, Garriga C, Prenafeta A, Moros A, Canete M, Barreiro A, et al.
Vaccine
. 2025 Jan;
47:126685.
PMID: 39809095
The HIPRA-HH-2 was a multicentre, randomized, active-controlled, double-blind, non-inferiority phase IIb clinical trial comparing the immunogenicity and safety of the PHH-1V adjuvanted recombinant vaccine as a heterologous booster against homologous...
2.
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2
Leal L, Pich J, Ferrer L, Nava J, Marti-Lluch R, Esteban I, et al.
NPJ Vaccines
. 2023 Sep;
8(1):147.
PMID: 37775521
In response to COVID-19 pandemic, we have launched a vaccine development program against SARS-CoV-2. Here we report the safety, tolerability, and immunogenicity of a recombinant protein RBD fusion heterodimeric vaccine...
3.
Corominas J, Garriga C, Prenafeta A, Moros A, Canete M, Barreiro A, et al.
Lancet Reg Health Eur
. 2023 May;
28:100613.
PMID: 37131861
Background: A SARS-CoV-2 protein-based heterodimer vaccine, PHH-1V, has been shown to be safe and well-tolerated in healthy young adults in a first-in-human, Phase I/IIa study dose-escalation trial. Here, we report...